Parkinson's Disease Diagnosis and Treatment Market Growth, Innovations and Market Size Forecast 2035
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 7.49 billion in 2025, is anticipated to reach USD 17.57 billion by 2035, growing at a CAGR of 8.9% over the next decade. In 2025, medications led the Parkinson’s disease market with a 40% share, while North America dominated at 38%. Asia Pacific is set to grow fastest, with a 7.0% CAGR. Key players include Siemens Healthineers, Abbott, GE, AbbVie, Merck, Pfizer, Teva, Sun Pharma, Novartis, and Cerevel Therapeutics.
Last Updated : 05 August 2026Category: Therapeutic AreaInsight Code: 5142Format: PDF / PPT / Excel
Regulatory framework for leading countries/regions
Supply demand analysis
Production & consumption statistics
Export Import statistics
Price trend analysis
Global Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa (MEA)
North America Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
Europe Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
South America Parkinson's Disease Diagnosis and Treatment Market Assessment
Overview
South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
Imaging Tests
Blood Tests
Other Tests
South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
Medications
Carbidopa-levodopa
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Anticholinergics
Others
Deep Brain Stimulation
Other Treatments
Company Profiles
Siemens Healthineers AG
Company overview
Geographic footprints
Financial performance
Product portfolio
SWOT analysis
R&D efforts
Recent developments & strategic collaborations
Product launch/M&A/Technical collaboration
Abbott Laboratories
General Electric Company
AbbVie
Merck & Co.
Pfizer
Teva Pharmaceutical Industries Ltd.
Sun Pharma
Novartis AG
Cerevel Therapeutics
Conclusion & Recommendations
FAQ's
Answer : The market is projected to grow from USD 7.49 billion in 2025 to USD 17.57 billion by 2035, expanding at a CAGR of 8.9% due to rising disease prevalence and technological advancements.
Answer : North America leads the market for Parkinsons disease diagnosis and treatment.
Answer : China is emerging as a clinical trial hub with a growing elderly population and favorable regulatory frameworks supporting Parkinson disease research.
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.